Diagnostic potential of miR-126, miR-143, miR-145, and miR-652 in malignant pleural mesothelioma

Journal of Molecular Diagnostics

Volumn 16, Issue 4, 2014, Pages 418-430

  Andersen, Morten ^a   Grauslund, Morten ^a   Ravn, Jesper ^a   Sørensen, Jens B ^a   Andersen, Claus B ^a   Santoni Rugiu, Eric ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; BIOLOGICAL MARKER; MICRORNA; MICRORNA 126; MICRORNA 143; MICRORNA 145; MICRORNA 652; UNCLASSIFIED DRUG; MIRN126 MICRORNA, HUMAN; MIRN143 MICRORNA, HUMAN; MIRN145 MICRORNA, HUMAN; MIRN652 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MRNA EXPRESSION ASSAY; PLEURA BIOPSY; PLEURA MESOTHELIOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; MESOTHELIOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; PLEURA; PLEURAL NEOPLASMS; PROCEDURES; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION;

AGED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MICRORNAS; MIDDLE AGED; PLEURA; PLEURAL NEOPLASMS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84903181755     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2014.03.002     Document Type: Article

References (46)

1. H.I. Pass, N. Vogelzang, S. Hahn, and M. Carbone Malignant pleural mesothelioma Curr Probl Cancer 28 2004 93 174
2. B.W. Robinson, A.W. Musk, and R.A. Lake Malignant mesothelioma Lancet 366 2005 397 408
3. A. Scherpereel, P. Astoul, P. Baas, T. Berghmans, H. Clayson, P. de Vuyst, H. Dienemann, F. Galateau-Salle, C. Hennequin, G. Hillerdal, C. Le Pechoux, L. Mutti, J.C. Pairon, R. Stahel, P. van Houtte, J. van Meerbeeck, D. Waller, W. Weder European Respiratory Society/European Society of Thoracic Surgeons Task F Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma Eur Respir J 35 2010 479 495
4. A.N. Husain, T. Colby, N. Ordonez, T. Krausz, R. Attanoos, M.B. Beasley, A.C. Borczuk, K. Butnor, P.T. Cagle, L.R. Chirieac, A. Churg, S. Dacic, A. Fraire, F. Galateau-Salle, A. Gibbs, A. Gown, S. Hammar, L. Litzky, A.M. Marchevsky, A.G. Nicholson, V. Roggli, W.D. Travis, M. Wick International Mesothelioma Interest Group Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group Arch Pathol Lab Med 137 2013 647 667
5. Z.G. Zimling, A. Jørgensen, and E. Santoni-Rugiu The diagnostic value of immunohistochemically detected methylthioadenosine phosphorylase deficiency in malignant pleural mesotheliomas Histopathology 60 2012 E96 E105
6. M. Shi, A.E. Fraire, P. Chu, K. Cornejo, B.A. Woda, K. Dresser, K.L. Rock, and Z. Jiang Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation Am J Surg Pathol 35 2011 878 882
7. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
8. S. Griffiths-Jones, R.J. Grocock, S. van Dongen, A. Bateman, and A.J. Enright miRBase: microRNA sequences, targets and gene nomenclature Nucleic Acids Res 34 Database issue 2006 D140 D144
9. R.C. Friedman, K.K. Farh, C.B. Burge, and D.P. Bartel Most mammalian mRNAs are conserved targets of microRNAs Genome Res 19 2009 92 105
10. M.D. Jansson, and A.H. Lund MicroRNA and cancer Mol Oncol 6 2012 590 610
11. D. Sayed, and M. Abdellatif MicroRNAs in development and disease Physiol Rev 91 2011 827 887
12. U. Siebolts, H. Varnholt, U. Drebber, H.P. Dienes, C. Wickenhauser, and M. Odenthal Tissues from routine pathology archives are suitable for microRNA analyses by quantitative PCR J Clin Pathol 62 2009 84 88
13. S. Volinia, G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R.L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C.C. Harris, and C.M. Croce A microRNA expression signature of human solid tumors defines cancer gene targets Proc Natl Acad Sci U S A 103 2006 2257 2261
14. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, J.R. Downing, T. Jacks, H.R. Horvitz, and T.R. Golub MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
15. S.L. Yu, H.Y. Chen, G.C. Chang, C.Y. Chen, H.W. Chen, S. Singh, C.L. Cheng, C.J. Yu, Y.C. Lee, H.S. Chen, T.J. Su, C.C. Chiang, H.N. Li, Q.S. Hong, H.Y. Su, C.C. Chen, W.J. Chen, C.C. Liu, W.K. Chan, W.J. Chen, K.C. Li, J.J. Chen, and P.C. Yang MicroRNA signature predicts survival and relapse in lung cancer Cancer Cell 13 2008 48 57
16. N. Yanaihara, N. Caplen, E. Bowman, M. Seike, K. Kumamoto, M. Yi, R.M. Stephens, A. Okamoto, J. Yokota, T. Tanaka, G.A. Calin, C.G. Liu, C.M. Croce, and C.C. Harris Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Cancer Cell 9 2006 189 198
17. S. Busacca, S. Germano, L. De Cecco, M. Rinaldi, F. Comoglio, F. Favero, B. Murer, L. Mutti, M. Pierotti, and G. Gaudino MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications Am J Respir Cell Mol Biol 42 2010 312 319
18. H. Benjamin, D. Lebanony, S. Rosenwald, L. Cohen, H. Gibori, N. Barabash, K. Ashkenazi, E. Goren, E. Meiri, S. Morgenstern, M. Perelman, I. Barshack, Y. Goren, T.B. Edmonston, A. Chajut, R. Aharonov, Z. Bentwich, N. Rosenfeld, and D. Cohen A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma J Mol Diagn 12 2010 771 779
19. L. Santarelli, E. Strafella, S. Staffolani, M. Amati, M. Emanuelli, D. Sartini, V. Pozzi, D. Carbonari, M. Bracci, E. Pignotti, P. Mazzanti, A. Sabbatini, R. Ranaldi, S. Gasparini, J. Neuzil, and M. Tomasetti Association of MiR-126 with soluble mesothelin-related peptides, a marker for malignant mesothelioma PLoS One 6 2011 e18232 http://dx.doi.org/10.1371/journal.pone. 0018232
20. G.V. Gee, D.C. Koestler, B.C. Christensen, D.J. Sugarbaker, D. Ugolini, G.P. Ivaldi, M.B. Resnick, E.A. Houseman, K.T. Kelsey, and C.J. Marsit Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma Int J Cancer 127 2010 2859 2869
21. M. Guled, L. Lahti, P.M. Lindholm, K. Salmenkivi, I. Bagwan, A.G. Nicholson, and S. Knuutila CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis Genes Chromosomes Cancer 48 2009 615 623
22. V. Balatti, S. Maniero, M. Ferracin, A. Veronese, M. Negrini, G. Ferrocci, F. Martini, and M.G. Tognon MicroRNAs dysregulation in human malignant pleural mesothelioma J Thorac Oncol 6 2011 844 851
23. M.B. Kirschner, Y.Y. Cheng, B. Badrian, S.C. Kao, J. Creaney, J.J. Edelman, N.J. Armstrong, M.P. Vallely, A.W. Musk, B.W. Robinson, B.C. McCaughan, S. Klebe, S.E. Mutsaers, N. van Zandwijk, and G. Reid Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma J Thorac Oncol 7 2012 1184 1191
24. D.G. Weber, G. Johnen, O. Bryk, K.H. Jöckel, and T. Brüning Identification of miRNA-103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma-a pilot study PLoS One 7 2012 e30221 http://dx.doi.org/10.1371/journal.pone.0030221
25. M. Tomasetti, S. Staffolani, L. Nocchi, J. Neuzil, E. Strafella, N. Manzella, L. Mariotti, M. Bracci, M. Valentino, M. Amati, and L. Santarelli Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients Clin Biochem 45 2012 575 581
26. M. Andersen, M. Grauslund, M. Muhammad-Ali, J. Ravn, J.B. Sorensen, C.B. Andersen, and E. Santoni-Rugiu Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma? APMIS 120 2012 767 769
27. T.D. Schmittgen, and K.J. Livak Analyzing real-time PCR data by the comparative C(T) method Nat Protoc 3 2008 1101 1108
28. K.A. Olaussen, A. Dunant, P. Fouret, E. Brambilla, F. Andre, V. Haddad, E. Taranchon, M. Filipits, R. Pirker, H.H. Popper, R. Stahel, L. Sabatier, J.P. Pignon, T. Tursz, T. Le Chevalier, J.C. Soria IALT Bio Investigators DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy N Engl J Med 355 2006 983 991
29. A.C. Vilmar, E. Santoni-Rugiu, and J.B. Sørensen ERCC1 and histopathology in advanced NSCLC patients randomized in a large multicenter phase III trial Ann Oncol 21 2010 1817 1824
30. A.C. Vilmar, E. Santoni-Rugiu, and J.B. Sørensen Class III β-tubulin in advanced NSCLC of adenocarcinoma subtype predicts superior outcome in a randomized trial Clin Cancer Res 17 2011 5205 5214
31. Z.G. Zimling, J.B. Sorensen, T.A. Gerds, C. Bech, C.B. Andersen, and E. Santoni-Rugiu Low ERCC1 expression in malignant pleural mesotheliomas treated with cisplatin and vinorelbine predicts prolonged progression-free survival J Thorac Oncol 7 2012 249 256
32. Z.G. Zimling, J.B. Sørensen, T.A. Gerds, C. Bech, C.B. Andersen, and E. Santoni-Rugiu A biomarker profile for predicting efficacy of cisplatin-vinorelbine therapy in malignant pleural mesothelioma Cancer Chemother Pharmacol 70 2012 743 754
33. D.G. Altman Practical Statistics for Medical Research 1991 Chapman and Hall London 351 358
34. J. Zhang, Q. Sun, Z. Zhang, S. Ge, Z.G. Han, and W.T. Chen Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop Oncogene 32 2013 61 69
35. A. Schaefer, M. Jung, H.J. Mollenkopf, I. Wagner, C. Stephan, F. Jentzmik, K. Miller, M. Lein, G. Kristiansen, and K. Jung Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma Int J Cancer 126 2010 1166 1176
36. E.F. Schisterman, N.J. Perkins, A. Liu, and H. Bondell Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples Epidemiology 16 2005 73 81
37. E. Miko, Z. Margitai, Z. Czimmerer, I. Várkonyi, B. Dezso, A. Lányi, Z. Bacsó, and B. Scholtz miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5 FEBS Lett 585 2011 1191 1196
38. M. Crawford, E. Brawner, K. Batte, L. Yu, M.G. Hunter, G.A. Otterson, G. Nuovo, C.B. Marsh, and S.P. Nana-Sinkam MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines Biochem Biophys Res Commun 373 2008 607 612
39. M. Tsuda, and S. Tanaka Roles for crk in cancer metastasis and invasion Genes Cancer 3 2012 334 340
40. K. Kaira, N. Oriuchi, T. Takahashi, K. Nakagawa, Y. Ohde, T. Okumura, H. Murakami, T. Shukuya, H. Kenmotsu, T. Naito, Y. Kanai, M. Endo, H. Kondo, T. Nakajima, and N. Yamamoto L-type amino acid transporter 1 (LAT1) expression in malignant pleural mesothelioma Anticancer Res 31 2011 4075 4082
41. R. Lulla, F.F. Costa, J.M. Bischof, P.M. Chou, F.B.M. de, E.F. Vanin, and M.B. Soares Identification of differentially expressed microRNAs in osteosarcoma Sarcoma 2011 2011 732690 http://dx.doi.org/10.1155/2011/732690
42. J. Gaedcke, M. Grade, J. Camps, R. Sokilde, B. Kaczkowski, A.J. Schetter, M.J. Difilippantonio, C.C. Harris, B.M. Ghadimi, S. Moller, T. Beissbarth, T. Ried, and T. Litman The rectal cancer microRNAome-microRNA expression in rectal cancer and matched normal mucosa Clin Cancer Res 18 2012 4919 4930
43. Z. Chen, H. Zeng, Y. Guo, P. Liu, H. Pan, A. Deng, and J. Hu miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc J Exp Clin Cancer Res 29 2010 151 http://dx.doi.org/10.1186/1756-9966-29-151
44. G. La Rocca, B. Shi, A. Audia, G. Ferrari-Amorotti, H.S. Mellert, B. Calabretta, S.B. McMahon, L. Sepp-Lorenzino, and R. Baserga Regulation of microRNA-145 by growth arrest and differentiation Exp Cell Res 317 2011 488 495
45. G. La Rocca, M. Badin, B. Shi, S.Q. Xu, T. Deangelis, L. Sepp-Lorenzinoi, and R. Baserga Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway J Cell Physiol 220 2009 485 491
46. I. Ahmad, L.B. Singh, Z.H. Yang, G. Kalna, J. Fleming, G. Fisher, C. Cooper, J. Cuzick, D.M. Berney, H. Møller, P. Scardino, and H.Y. Leung Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer Br J Cancer 108 2013 149 154